Cyclopharm (CYC) and the US Growth Opportunity | Meet the CEO
Meet the CEO: Cyclopharm and the US opportunity Cyclopharm has established a foothold in the world’s largest healthcare market. The question now is how big its US business can…
The Week Ahead: NEXTDC, MAQ and Nick Scali: Buy the Dip?
AI remains a powerful investment theme. But the amount of money being poured into data centres is prompting a harder question: which businesses can turn that investment into returns for…
CSL: Why taking profits is part of good investing
Investing is about finding good businesses, paying the right price and knowing when to bank some of the gains. That last step can be the hardest. When a stock is…
#GetRichwithRich
Rich updates you on the market and his top stocks of the week.
ASX Stock Pulse
Learn more about the latest ASX Small Caps
ASX Sector Analysis
Rich updates you on the market and his top stocks of the week.
Fund Manager Series
Rich updates you on the market and his top stocks of the week.
Get Instant Access
Bundle up and Save!
